Avita Medical, Inc. - Common Stock (RCEL)

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.

Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 18% from a year earlier and 13% sequentially, as growth in its RECELL wound-care product and newer portfolio offerings supported results. President and Chief Executive Officer Cary Vance said the company’s U.S. RE

Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics (NASDAQ:LSTA)

Avita (RCEL) Q1 2026 Earnings Call Transcript

Avita Medical (NASDAQ:RCEL) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook as management said reimbursement conditions for its RECELL product are normalizing and demand patterns are becoming more consistent. The regenerative medicine company posted first-quarter rev

AVITA Medical (RCEL) Q4 2025 Earnings Transcript

AVITA Medical (RCEL) Q3 2025 Earnings Transcript

AVITA Medical's Q3 revenue missed estimates due to reimbursement headwinds, but the company improved cost control and secured key Medicare pricing.

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.